Please provide your email address to receive an email when new articles are posted on . Medication errors that happen in schools are the same that occur in other settings, an expert said. New AAP ...

Final negotiations for the most important international trade deal of the century have just hit a snag. Earlier this month, officials from a dozen major and emerging economies, including the United ...

Pfizer is rated a buy due to its robust drug pipeline, focus on improving financials, and significant long-term growth potential despite near-term headwinds. PFE delivered strong results in H1, with ...

Researchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Department of Clinical Neurosciences have identified a novel mechanism by which ...

With hundreds of drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions and mitigate financial losses. These include ...

From the time that the Centers for Medicare and Medicaid Services (CMS) first provided public guidance on its intended approach for negotiating the price of the first 10 drugs selected for Medicare’s ...

The largest American public healthcare companies outperformed other industries in the third quarter, as higher new and specialty drug use, continued demand for weight-loss drugs and strong hospital ...

First-half operating profit growth beats analyst estimates Revenue from eye drug Vabysmo nearly doubles, beats estimates Expects close to 10% adjusted profit growth, up vs previous Shares traded near ...

Novo Holdings reported a 2024 income of 60B Danish kroner, with its investment portfolio delivering an 18% return, up from 9.4% in 2023. Novo Holdings added 43 new companies to its portfolio in 2024, ...